Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000967704 | SCV001115114 | likely benign | 2-aminoadipic 2-oxoadipic aciduria | 2024-01-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001726398 | SCV001473908 | benign | not provided | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726398 | SCV002497019 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | DHTKD1: BP4, BS2 |
Breakthrough Genomics, |
RCV001726398 | SCV005226916 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Elsea Laboratory, |
RCV000967704 | SCV001424216 | likely benign | 2-aminoadipic 2-oxoadipic aciduria | 2020-04-01 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001699490 | SCV001923289 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001726398 | SCV001963320 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003916242 | SCV004731308 | likely benign | DHTKD1-related disorder | 2022-08-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |